普莱柯生物工程股份有限公司关于使用闲置募集资金进行现金管理到期赎回的公告

Group 1 - The company has approved the use of idle raised funds for cash management, with a limit of up to RMB 265 million [2] - The cash management plan was approved during meetings held on August 29, 2024, and September 19, 2024, ensuring the safety and normal operation of the raised funds [2] - The cash management period is valid for 12 months from the date of approval by the shareholders' meeting [2] Group 2 - As of August 22, 2025, the company has fully redeemed all idle raised funds used for cash management and returned them to the designated account [3] - The company has informed the sponsor institution, Huatai United Securities, about the redemption of the raised funds [3] - The cash management activities were conducted within the approved amount and timeframe, with all financial products maturing and redeemed as planned [3]